Novartis chief executive Daniel Vasella might propose current Vaccines & Diagnostics chief executive Joerg Reinhardt as his successor, according to an article in Swiss weekly SonntagsZeitung.
With shrinking margins and pressure on its stock price, Novartis could use the breath of fresh air inspired by the naming of a new chief executive, said the report.
Vasella has in the past been criticised over his dual mandate as chairman and CEO.
Source
No comments:
Post a Comment